| Gene | Uniprot | Gene Full Name | Protein Class | pLI | DSI v | DPI v |
|---|---|---|---|---|---|---|
| ABO | P16442 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | Enzyme | 0.427 | 0.885 | |
| PVT1 | Pvt1 oncogene | 0.495 | 0.731 | |||
| GAS5 | growth arrest specific 5 | 0.497 | 0.808 | |||
| LINC02210-CRHR1 | P34998 | LINC02210-CRHR1 readthrough | 0.570 | 0.692 | ||
| CASC15 | cancer susceptibility 15 | 0.603 | 0.577 | |||
| MIR4435-2HG | MIR4435-2 host gene | 0.604 | 0.692 | |||
| LUCAT1 | lung cancer associated transcript 1 | 0.612 | 0.577 | |||
| CCDC26 | Q8TAB7 | CCDC26 long non-coding RNA | 0.647 | 0.615 | ||
| RAB4B-EGLN2 | RAB4B-EGLN2 readthrough (NMD candidate) | 0.641 | 0.654 | |||
| LINC-PINT | long intergenic non-protein coding RNA, p53 induced transcript | 0.663 | 0.577 | |||
| NBAT1 | neuroblastoma associated transcript 1 | 0.650 | 0.423 | |||
| ACTN3 | Q08043 | actinin alpha 3 (gene/pseudogene) | 0.663 | 0.500 | ||
| MAPT-AS1 | MAPT antisense RNA 1 | 0.711 | 0.269 | |||
| ZFPM2-AS1 | ZFPM2 antisense RNA 1 | 0.736 | 0.385 | |||
| TEX41 | testis expressed 41 | 0.743 | 0.269 | |||
| LINC01122 | long intergenic non-protein coding RNA 1122 | 0.821 | 0.269 | |||
| CMAHP | Q9Y471 | cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene | 0.805 | 0.346 | ||
| MEF2C-AS1 | MEF2C antisense RNA 1 | 0.861 | 0.154 | |||
| CCDC162P | coiled-coil domain containing 162, pseudogene | 0.890 | 0.154 | |||
| VLDLR-AS1 | VLDLR antisense RNA 1 | 0.821 | 0.115 | |||
| LINC00271 | P0C7V0 | long intergenic non-protein coding RNA 271 | 0.769 | 0.192 | ||
| MFF-DT | MFF divergent transcript | 0.780 | 0.269 | |||
| PAX8-AS1 | PAX8 antisense RNA 1 | 0.792 | 0.231 | |||
| LINC01478 | long intergenic non-protein coding RNA 1478 | 1.000 | 0.077 | |||
| ZMIZ1-AS1 | ZMIZ1 antisense RNA 1 | 0.780 | 0.115 |